Package 68001-484-85

Brand: fulvestrant

Generic: fulvestrant
NDC Package

Package Facts

Identity

Package NDC 68001-484-85
Digits Only 6800148485
Product NDC 68001-484
Product ID 68001-484_384e7b1e-9100-97cc-e063-6394a90afb72
Description

2 SYRINGE, GLASS in 1 CARTON (68001-484-85) / 5 mL in 1 SYRINGE, GLASS (68001-484-86)

Marketing

Marketing Status
Marketed Since 2021-03-01
Brand fulvestrant
Generic fulvestrant
Sample Package No

Linked Drug Pages (1)

Fulvestrant ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR"], "spl_id": "384e7b1e-9100-97cc-e063-6394a90afb72", "openfda": {"nui": ["N0000175582", "N0000000145", "N0000000168"], "unii": ["22X328QOC4"], "rxcui": ["727762"], "spl_set_id": ["bc7b4eac-3b63-53d2-e053-2995a90ad5e7"], "pharm_class_epc": ["Estrogen Receptor Antagonist [EPC]"], "pharm_class_moa": ["Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, GLASS in 1 CARTON (68001-484-85)  / 5 mL in 1 SYRINGE, GLASS (68001-484-86)", "package_ndc": "68001-484-85", "marketing_start_date": "20210301"}], "brand_name": "Fulvestrant", "product_id": "68001-484_384e7b1e-9100-97cc-e063-6394a90afb72", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Estrogen Receptor Antagonist [EPC]", "Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "68001-484", "generic_name": "Fulvestrant", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fulvestrant", "active_ingredients": [{"name": "FULVESTRANT", "strength": "250 mg/5mL"}], "application_number": "ANDA210044", "marketing_category": "ANDA", "marketing_start_date": "20210301", "listing_expiration_date": "20261231"}